Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infections - 08/04/25
, Carlota Dobaño a, b, j, ⁎, 1 
Summary |
Objectives |
Repeated COVID-19 mRNA vaccinations increase SARS-CoV-2 IgG4 antibodies, indicating extensive IgG class switching following the first booster dose. This shift in IgG subclasses raises concerns due to the limited ability of IgG4 to mediate Fc-dependent effector functions.
Methods |
To assess the impact of IgG4 induction on protective immunity, we analyzed longitudinal SARS-CoV-2 IgG subclasses, C1q and FcγR responses, and neutralizing activity in a well-characterized cohort of healthcare workers in Spain.
Results |
Elevated IgG4 levels and higher ratios of non-cytophilic to cytophilic antibodies after booster vaccination were significantly associated with an increased risk of breakthrough infections (IgG4 HR[10-fold increase]=1.8, 95% CI=1.2–2.7; non-cytophilic to cytophilic ratio HR[10-fold increase]=1.5, 95% CI=1.1–1.9). Moreover, an increased non-cytophilic to cytophilic antibody ratio correlated with reduced functionality, including neutralization.
Conclusions |
These findings suggest a potential association between IgG4 induction by mRNA vaccination and a higher risk of breakthrough infection, warranting further investigation into vaccination strategies to ensure sustained protection.
Le texte complet de cet article est disponible en PDF.Highlights |
• | IgG4 and IgG2 levels increase markedly after the third mRNA dose against SARS-CoV-2. |
• | Elevated IgG4 levels after booster vaccination associate with an increased risk of infections. |
• | Increased non-cytophilic to cytophilic antibody ratio correlates with reduced functionality. |
Keywords : SARS-CoV-2, Humoral immunity, COVID-19 mRNA vaccines, SARS-CoV-2-specific antibodies, Fc effector function
Plan
Vol 90 - N° 4
Article 106473- avril 2025 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
